Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ILMN · against 588 other Healthcare companies listed in US-listed
Ranked #183 of 589 · scores higher than 68% of peers
Bars: peers in each 10-point band of the valuation score57 peers with a valuation score of 50–59, including ILMN · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | ILMN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 2.3% | -4.3% | 73% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 3.1% | -0.8% | 62% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 2.7% | -2.3% | 69% | 20% | |
| Book yieldHigher is better · 587 reported | 7.9% | 25.9% | 21% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 178 | 34.0B USD | 51 | 49 | |
| 178 | 11.9B USD | 51 | 53 | |
| 178 | 4.0B USD | 51 | 72 | |
| 183 | 2.5B USD | 50 | 32 | |
| 183 | 36.0B USD | 50 | 46 | |
| 183 | 9.0B USD | 50 | 78 | |
| 183 | 6.3B USD | 50 | 78 | |
| 183 | 126.5B USD | 50 | 56 | |
| 183 | 38.4B USD | 50 | 50 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score